Statement from Private Healthcare Australia CEO Dr Rachel DavidThe Federal Government’s decision to wind-back the planned removal of general use items from the Prescribed List of Medical Devices and Human Tissue (PL) on 1 July is likely to impact the cost of private health insurance premiums for 15 million Australians.Health funds are…
Read More…
Source: https://www.miragenews.com/higher-health-insurance-premiums-risked-by-1225726/